Commonly Used drugs in IV conscious sedation Flashcards
Normal, Healthy patient without systemic disease
ASA I:
: Mild systemic disease
ASA II
Severe systemic disease, limits activity but no
incapacitating
ASA III:
Incapacitating systemic disease that is constant threat to life
ASA IV:
Not to survive 24 hours with/without operation
ASA V:
Brain-dead patient awaits for organ donation
ASA VI:
: Emergency operation
Precedes number status ( i.e. ASA E-II)
ASA E
Reduction of irritability or agitation by administration of
sedative drugs, generally to facilitate a medical procedure
sedation
A drug induced depression of consciousness during which
patients respond purposefully to verbal commands, either alone
or accompanied by light tactile stimulation.
Generally, no interventions are required to maintain a patent
airway, and spontaneous ventilation is adequate.
Cardiovascular function is usually maintained.
Moderate sedation
A drug-induced depression of consciousness during which
patients cannot be easily aroused but respond purposefully
following repeated or painful stimulation.
The ability to independently maintain ventilatory function may be
impaired.
Patients may require assistance in maintaining a patent airway
and spontaneous ventilation may be inadequate.
Cardiovascular function is usually maintained.
Deep sedation
Common Medication used in ______
Barbiturate
Propofol
Ketamine
Benzodiazepine
Opioids
IV Sedation
General Properties
Desirable Effect
Analgesia
Sedation
Euphoria
Anti-tussive
Undesirable Effect
Respiratory Depression
Coma
Emesis
Constipation
Histamine release
Potential for addiction
Opiods
Mechanism of action
○ Edinger-Westphal nucleus of Oculomotor nerve
○ Enhanced parasympathetic stimulation
Significance?
○ Most other causes of coma and respiratory depression produce
mydriasis (dilation of pupil)
All Addicts demonstrate pin-point pupils
Miosis
The Gold Standard of pain med
Pharmacology
IM / IV
Hyperpolarize nerve cell, ↓release of substance P
Least lipophilic minimum crossing to BBB
Onset 5-10mins, peak within 30mins
T ½ 1.5 – 2 hours
Duration of action : 4-6 hours
Do not give to neonate (unable to conjugate)
Metabolism
Conjugate with glucuronic acid
○ Morphine-6-glucuronide (potent analgesic)
○ Morphine-3-glucuronide (inactive)
Elimination
End product eliminated by kidney
Renal failure patient may have narcosis and vent failure for days !
Adverse Effect
Nausea and Vomiting
○ Stimulate medullary chemoreceptor trigger zone
Severe respiratory depression
○ Rigid chest syndrome
Histamine Release
○ May lead to profound drop in BP and systemic vascular resistance
Morphine
100X potency of morphine
Pharmacology
Oral / IV / Transdermal
Analgesic and Sedative effect
High Lipid solubility rapid onset / short duration
Onset of action < 60 sec with peak effect in 2 – 5 mins
Duration 30 – 60 mins
Metabolism
Inactive metabolite
○ Remember the “end “ of the effect is due to redistribution!!
○ Fentanyl will accumulate in body fat with repeated injections
Elimination
Little effect on renal patient
Clearance dependent on hepatic blood flow
Adverse Effect
No histamine release
Rigid Chest Syndrome
○ After large drug bolus !!
Fentanyl